Deletion of fibroblast activation protein provides atheroprotection

Fibroblast activation protein (FAP) is upregulated at sites of tissue remodeling including chronic arthritis, solid tumors, and fibrotic hearts. It ha...

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018

Across 26 current ACC/AHA guidelines, 8.5% of recommendations were classified as LOE A. When comparing current guidelines with prior versions, the pro...

Published Articles Reporting Studies by Industry Employees on Interventional Cardiology Devices

Findings were based on studies published between January 1, 2010, and December 31, 2012. Authors with IEAs were significantly more likely to report po...

Hypertension

Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even after normalization of blood pressure in patients with...

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients

Systemic hypertension is the most common comorbidity among cancer patients. Cancer and hypertension have common risk factors, have overlapping pathoph...

Role of the Peroxisome Proliferator Activated Receptors in Hypertension

Nuclear receptors represent a large family of ligand-activated transcription factors which sense the physiological environment. We will focus on the P...